The Only FDA Cleared 24/7 Wearable for Chronic Pain Relief
NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell Wearable
Pain Relief Technology™ will be featured at the American Academy of Pain
Medicine (AAPM) Annual Meeting in Palm Springs, California at the Palm
Springs Convention Center on February 18-21.
"With over 100 million Americans suffering from chronic pain, and many
of them getting inadequate relief from their pain medications or
suffering side effects, there are significant unmet needs in pain
management," said Shai N. Gozani, M.D., Ph.D., President and Chief
Executive Officer of NeuroMetrix. "We are pleased to take part in the
AAPM annual meeting and will share the role that Quell’s innovative
technology can play in the management of chronic pain. Quell is a new
100% drug free technology that addresses a variety of chronic pain
conditions. Patients can wear it 24/7 and continue to derive therapeutic
benefit even while sleeping."
About Quell
Quell utilizes NeuroMetrix's patented neurostimulation technology to
provide widespread relief from chronic pain. The advanced wearable
device is lightweight and can be worn during the day while active, and
at night while sleeping. It has been cleared by the FDA for treatment of
chronic pain. In a recent study, 81% of Quell users reported an
improvement in their chronic pain. Quell includes a smartphone app that
tracks and personalizes their pain therapy. It is available for purchase
at QuellRelief.com,
selected retailers and healthcare professionals.
About the American Academy of Pain Medicine
Founded in 1983, the American Academy of Pain Medicine (AAPM) is the
premier scientific and educational association for pain physicians and
their treatment teams. The AAPM has a membership of nearly 2,400 medical
professionals.
About NeuroMetrix
NeuroMetrix is an innovative healthcare company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160210005331/en/
Copyright Business Wire 2016